OEM News

RhythMedix Introduces Next-Gen RhythmStar SL Cardiac Monitor

The product advances remote cardiac monitoring with faster insights, greater comfort, and seamless connectivity.

By: Michael Barbella

Managing Editor

The next-generation RhythmStar SL cardiac monitor enhances the patient experience and simplifies remote monitoring. Photo: PR Newswire.

RhythMedix LLC has launched its next-generation RhythmStar SL cardiac monitoring wearable that enhances the patient experience by improving comfort, wearability, and patient adherence. The advancements are achieved through a compact lead configuration, waterproof IPX-6 rating, and increased battery life.

“RhythmStar represents our commitment to delivering a better way to monitor, one that prioritizes both patient comfort and clinical performance,” RhythMedix CEO Brian Pike stated. “By combining a more wearable design with seamless data transmission and expert review, we’re helping clinicians access the insights they need, when they need them.”

RhythmStar continues to differentiate its products through built-in cellular connectivity, enabling ECG data to be automatically transmitted to the cloud for seamless, prompt review across all monitoring modes—without requiring the device to be returned by mail for data processing.

When paired with the company’s proprietary Augmented Arrhythmia Intelligence (AAI), RhythmStar SL delivers precise arrhythmia detection by combining advanced algorithms with a multi-layered data review process, according to the company.

“RhythMedix is taking a truly visionary approach to cardiac monitoring by combining patient-friendly design with advanced technology and expert oversight, helping clinicians make more confident, timely decisions,” stated George Shaw, M.D., an electrophysiologist at AHN Allegheny Health Network. “It’s a meaningful step forward in how we deliver and manage cardiac care.”

With more than 2 million hearts monitored to date, RhythMedix advances remote cardiac monitoring through technology designed to improve both patient adherence and clinical workflow.

Founded in 2013 and headquartered in Mount Laurel, N.J., RhythMedix is a fully integrated cardiac monitoring company providing end-to-end device manufacturing, software development, and 24/7 U.S.-based monitoring services. With no third-party dependence, RhythMedix delivers a seamless and secure remote cardiac monitoring experience for clinics, health systems, and patients nationwide.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters